Other

Accrued settlement liabilities

Idexx Laboratories Accrued settlement liabilities increased by 27.1% to $10.80M in Q1 2026 compared to the prior quarter.

Analysis

StatementBalance Sheet Statement
SectionOther
First reportedQ4 2025
Last reportedQ1 2026
Metric ID: other_share_repurchase_program_settlement_liabilities_current

Historical Data

2 periods
 Q4 '25Q1 '26
Value$8.50M$10.80M
QoQ Change—+27.1%
Range$8.50M – $10.80M

Frequently Asked Questions

What is Idexx Laboratories's accrued settlement liabilities?
Idexx Laboratories (IDXX) reported accrued settlement liabilities of $10.80M in Q1 2026.